ReviewAAPS PharmSciTech2026
Functional Hybrid Wound Scaffolds for Controlled Drug Delivery and Smart Wound Management: A Decade of Progress.
Review in AAPS PharmSciTech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In order to avoid exogenous infections and promote healing, wound scaffolds (WS), an artificial barrier that separates the damaged location from the outside world, are a crucial part of wound care. Traditional wound dressings are widely used, although they have disadvantages such poor moisture retention and biocompatibility. Systems for scaffold-mediated delivery have developed as innovative ways to solve issues and improve patient outcomes. By enabling controlled and targeted drug delivery, they provide benefits in fostering an environment that is favorable for wound healing. The effectiveness of these systems for managing skin wounds can be increased by using functional wound scaffold (FWS) made from hybrid biological macromolecule-based materials. With an emphasis on hybrid biomaterials, methods, and applications developed within the previous decade years, the review seeks to give a broad overview of the most advanced FWS in the field of wound care. Furthermore, we emphasize the development of smart WS, the integration of biological macromolecules in WS. This study clarifies the promising potential of scaffold-mediated drug delivery in enhancing treatment outcomes and optimizing wound care practices through a synthesis of experimental results and recent literature. Furthermore, this review emphasizes the challenges and potential for the future of combining wound detection and therapy.
Indexed as
Identifiers
42259983What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.